SEC Form 4 · accession 0001193125-26-256039
Viking Therapeutics, Inc. · VKTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Hubert C Chen
Officer — Chief Medical Officer
Period of report
Jun 1, 2026
Accepted (ET)
Jun 3, 2026 · 7:44 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001607678
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $31.27 | Jun 1, 2026 | A | 190,000 | A | — | Jun 1, 2036 | Common Stock | 190,000 | 190,000 | D |
Explanation of responses
- F125% of the shares subject to the option vested immediately, and 25% of the shares subject to the option will vest on each one-year anniversary of the grant date over the next three years.